Existing studies have shown that the programmed cell death protein 1 (PD-1)/programmed cell death ligand 1 (PD-L1) signaling pathway can induce tumor-specific T cell apoptosis by inhibiting T cell activation [5]. This evidence concerns the gene PDCD1 and neoplasm.